7/22/2024  9:59:51 PM Chg. +0.02 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
35.36USD +0.06% 58,394
Turnover: 2.06 mill.
-Bid Size: - -Ask Size: - 18.02 bill.USD 3.28% 6.74

Business description

Baxter and the Baxter International Foundation are committed to saving and sustaining lives and creating healthier communities. The company focuses on three core areas including improving access to healthcare; fostering tomorrow’s innovation and serving its communities. Baxter works closely with public and private partners around the world to ensure people have access to the healthcare they need, to develop the next generation of innovators who will lead the way in advancing care, and to create long-lasting impact in Baxter’s communities. The Baxter International Foundation supports initiatives and organizations that make a positive, lasting impact on increasing access to healthcare for the disadvantaged and underserved.

Management board & Supervisory board

Jose (Joe) E. Almeida
Management board
James Borzi, Stacey Eisen, Darren Evans, Gerard (Jerry) Greco, Tobi Karchmer, Heather Knight, Talvis Love, Jeanne Mason, Reazur (Reaz) Rasul, David S. Rosenbloom, Alok Sonig, Brian Stevens, Chris Toth, Steve Wallace, Daniel (Dan) Wolf
Supervisory board
Jose (Joe) E. Almeida, William A. Ampofo II, Michael F. Mahoney, Patricia B. Morrison, Ste hen N. Oesterle, Stephen H. Rusckowski, Nancy M. Schlichting, Brent Shafer, Cath R. Smith, Amy A. Wendell, David S. Wilkes, Peter M. Wilver

Company data

Name: Baxter International Inc.
Address: One Baxter Parkway,Deerfield, IL 60015, USA
Phone: +1-224-948-2000
Fax: -
E-mail: -
Internet: www.baxter.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 73.60%
IPO date: 1/13/1978

Investor relations

Name: Clare Trachtman
IR phone: +1-224-948-3020
IR Fax: +1-224-948-4498
IR e-mail: Global_CORP_Investor...ter.com Global_CORP_Investor_Relations@baxter.com

Company calendar

CW 32 | 8/6/2024 Interim Report 2nd Quarter/6 Months
CW 35 | 8/30/2024 Record Date
CW 40 | 10/1/2024 Dividend Payment

Main Shareholders

Blackrock Inc.
Vanguard Group Inc
State Street Corporation
Price (T.Rowe) Associates Inc
Geode Capital Management, LLC
Ameriprise Financial, Inc.
JP Morgan Chase & Company
Invesco Ltd.